Literature DB >> 16413985

Post-mortem fetal MRI: what do we learn from it?

E H Whitby1, M N J Paley, M Cohen, P D Griffiths.   

Abstract

Post-mortem magnetic resonance (MR) imaging is of increasing interest not only as an alternative to autopsy but as a research tool to aid the interpretation and diagnosis of in utero MR images. The information from the post-mortem MR has allowed the development of imaging sequences applicable to in utero imaging and neonatal imaging. It has established brain development during gestation and has provided data on this to which in utero MR can be compared. The detail available from the post-mortem images is such that brain development can be studied in a non-invasive manner, a permanent record on the normal and abnormal areas is available and a greater understanding of developmental abnormalities is possible.

Entities:  

Mesh:

Year:  2006        PMID: 16413985     DOI: 10.1016/j.ejrad.2005.11.024

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  11 in total

1.  The use of magnetic resonance in the hospital and coronial pediatric postmortem examination.

Authors:  M C Cohen; E Whitby
Journal:  Forensic Sci Med Pathol       Date:  2007-12       Impact factor: 2.007

2.  Foetal "black bone" MRI: utility in assessment of the foetal spine.

Authors:  A J Robinson; S Blaser; A Vladimirov; D Drossman; D Chitayat; G Ryan
Journal:  Br J Radiol       Date:  2014-12-11       Impact factor: 3.039

3.  Intrauterine fetal MR versus postmortem MR imaging after therapeutic termination of pregnancy: evaluation of the concordance in the detection of brain abnormalities at early gestational stage.

Authors:  Giana Izzo; Giacomo Talenti; Giorgia Falanga; Marco Moscatelli; Giorgio Conte; Elisa Scola; Chiara Doneda; Cecilia Parazzini; Mariangela Rustico; Fabio Triulzi; Andrea Righini
Journal:  Eur Radiol       Date:  2018-12-12       Impact factor: 5.315

4.  Development of the subcortical brain structures in the second trimester: assessment with 7.0-T MRI.

Authors:  Haiwei Meng; Zhonghe Zhang; Hequn Geng; Xiangtao Lin; Lei Feng; Gaojun Teng; Fang Fang; Fengchao Zang; Shuwei Liu
Journal:  Neuroradiology       Date:  2012-07-19       Impact factor: 2.804

5.  Post-mortem magnetic resonance foetal imaging: a study of morphological correlation with conventional autopsy and histopathological findings.

Authors:  Annamaria Vullo; Valeria Panebianco; Giuseppe Cannavale; Mariarosaria Aromatario; Luigi Cipolloni; Paola Frati; Alessandro Santurro; Francesco Vullo; Carlo Catalano; Vittorio Fineschi
Journal:  Radiol Med       Date:  2016-07-27       Impact factor: 3.469

6.  Postmortem magnetic resonance imaging as an adjunct to perinatal autopsy for renal-tract abnormalities.

Authors:  C F Hagmann; N J Robertson; V R Sams; J A S Brookes
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-05       Impact factor: 5.747

7.  Postmortem computed tomography and magnetic resonance imaging in a case of terminal-stage small cell lung cancer: an experience of autopsy imaging in tumor-related death.

Authors:  Go Ikeda; Ryoo Yamamoto; Masatsune Suzuki; Hiroichi Ishikawa; Kazunori Kikuchi; Seiji Shiotani
Journal:  Radiat Med       Date:  2007-02-27

8.  Diffusion-weighted perinatal postmortem magnetic resonance imaging as a marker of postmortem interval.

Authors:  Owen J Arthurs; Gemma C Price; David W Carmichael; Rod Jones; Wendy Norman; Andrew M Taylor; Neil J Sebire
Journal:  Eur Radiol       Date:  2014-12-18       Impact factor: 5.315

Review 9.  Perinatal post-mortem magnetic resonance imaging (MRI) of the central nervous system (CNS): a pictorial review.

Authors:  Carlos Pérez-Serrano; Álvaro Bartolomé; Núria Bargalló; Carmen Sebastià; Alfons Nadal; Olga Gómez; Laura Oleaga
Journal:  Insights Imaging       Date:  2021-07-22

Review 10.  Post-mortem MRI as an alternative to non-forensic autopsy in foetuses and children: from research into clinical practice.

Authors:  S Addison; O J Arthurs; S Thayyil
Journal:  Br J Radiol       Date:  2014-04       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.